India Fat-Loss Drug Sales Slow After Early Spike From Generics
Source:
bloombergMarkets
July 8, 2026 · 00:41
Growth in India’s obesity- and diabetes-drug market is losing steam just months after a surge triggered by the arrival of generic semaglutide products.
The original article opens on the publisher's website.
More from Gaming
View topic →China dissented from G20 statement opposing 'cheap exports' flooding market, Bessent says
cnbc
Sep 1, 2026 · 16:52
Skip the 5K monitor for gaming and go with a 4K instead — here's why
engadget
Sep 1, 2026 · 15:00
US diesel prices soar as Trump hauls in refiners
financialTimes
Sep 1, 2026 · 14:18
Anthropic's Claude Fable 5.1 and Mythos 5.1 arrive with a 75% cost reduction for Fable cache reads
ventureBeat
Sep 1, 2026 · 11:41
Prediction market traders think job creation rebounded in August
cnbc
Sep 1, 2026 · 11:16
Countries mentioned